Cancer cells resist antibody-mediated destruction by neutrophils through activation of the exocyst complex

• Sung-Bae Kim,
• Taco W Kuijpers,
• Christos Sotiriou,
• Serena Di Cosimo,
• Jens Huober,
• Rebecca Roylance,
• Anton T J Tool,
• Dieke J van Rees,
• Bart Klein,
• Panagiota Bouti,
• Karin Schornagel,
• Robin van Bruggen,
• Hanke L Matlung,
• Paul J H Verkuijlen,
• Michel van Houdt,
• David Venet,
• Sarra El-Abed,
• Miguel Izquierdo,
• Sébastien Guillaume,
• Cristina Saura,
• Timo K van den Berg

Affiliations

Sung-Bae Kim

8Asan Medical Center, Seoul, Korea, Republic of

Taco W Kuijpers

Department of Pediatric Immunology, Rheumatology and Infectious diseases, Emma Children`s Hospital, Amsterdam University Medical Centres, University of Amsterdam, Amsterdam, The Netherlands

Christos Sotiriou

Aff2 grid.418119.4000000010684291XBreast Cancer Translational Research Laboratory J.C. HeusonInstitut Jules Bordet Bruxelles Belgium

Serena Di Cosimo

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy

Jens Huober

Universitätsklinikum Ulm, Ulm, Baden-Württemberg, Germany

Rebecca Roylance

7UCLH Foundation Trust, London, UK

Anton T J Tool

1 Sanquin Blood Cell Research and Landsteiner Laboratory, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

Dieke J van Rees

Department of Blood Cell Research, Sanquin Research, Amsterdam, The Netherlands

Bart Klein

Department of Blood Cell Research, Sanquin Research, Amsterdam, The Netherlands

Panagiota Bouti

Department of Blood Cell Research, Sanquin Research, Amsterdam, The Netherlands

Karin Schornagel

Department of Blood Cell Research, Sanquin Research, Amsterdam, The Netherlands

Robin van Bruggen

Department of Blood Cell Research, Sanquin Research, Amsterdam, The Netherlands

Hanke L Matlung

Department of Blood Cell Research, Sanquin Research, Amsterdam, The Netherlands

Paul J H Verkuijlen

Department of Molecular Hematology, Sanquin Research, Amsterdam, The Netherlands

Michel van Houdt

Department of Molecular Hematology, Sanquin Research, Amsterdam, The Netherlands

David Venet

Breast Cancer Translational Research Laboratory JC Heuson, Institut Jules Bordet, Bruxelles, Belgium

Sarra El-Abed

Breast International Group, Brussels, Belgium

Miguel Izquierdo

Novartis Pharma AG, Basel, Switzerland

Sébastien Guillaume

Department of Psychiatric Emergency & Acute Care, Lapeyronie Hospital, Montpellier, France

Cristina Saura

SOLTI Innovative Breast Cancer Research, Vall d’Hebron Hospital Universitari, Barcelona, Spain

Timo K van den Berg

Department of Molecular Hematology, Sanquin Research, Amsterdam, The Netherlands